Laboratory specimen processing
Health Boards should ensure that there is no unnecessary delay in processing laboratory specimens, in reporting positive results and in commencing specific antibiotic treatment.
- The Scottish Government's response outlined the HAI Taskforce's role in developing antimicrobial prescribing guidelines and the Controlling Antimicrobial Resistance in Scotland (CARS) programme, which monitors prescribing practices across NHS boards.
- The Scottish Antimicrobial Prescribing Group (SAPG) provides national leadership on antimicrobial stewardship, including guidelines, monitoring, and reporting. NHS board antimicrobial management teams drive implementation locally.
- The HCAI Strategy 2023-2025 includes antimicrobial resistance as a key priority, with surveillance and stewardship programmes ensuring that there is no unnecessary delay in processing lab specimens and commencing treatment (Scottish HCAI Strategy 2023-2025 (https://www.gov.scot/publications/scottish-healthcare-associated-infection-hcai-strategy-2023-2025/)).
- ARHAI Scotland provides national surveillance data on antimicrobial resistance and prescribing patterns to support policy implementation.
How was this evidence gathered?
Response
Accepted
Response
AcceptedSection 3.2 of the Scottish Government's response highlights that NHS board antimicrobial management teams (AMTs) drive comprehensive approaches to education on antimicrobial stewardship for clinical staff and promote application of antimicrobial policies. Section 4.2 details how eHealth initiatives, including the TrakCare patient management system and an online clinical portal at VOLH, enable electronic storage and sharing of images, results, and diagnoses. These technological developments enhance healthcare workers' ability to order and report diagnostic tests electronically, aiming to streamline information flow and support timely treatment.
Published Evidence
Published assessments of progress from inspectorates, select committees, official progress reports, and other sources. Source type badge indicates whether each assessment is independent or government self-reported.
NIPCM provides guidance on laboratory specimen handling and CDI testing. National surveillance system requires timely reporting of positive results.
View detailed findings
CDI testing turnaround times are monitored as part of national surveillance quality indicators.